Technologies

Fecal Neopterin Concentration Measurement as an Indicator of Disease Activity in Crohn's Disease or Ulcerative Colitis

Technology description

Identification of a new biomarker for inflammatory bowel disease (IBD).

#diagnositics #helathcare #diagnostictool #gastroenterology

A Northwestern researcher has identified a new biomarker for inflammatory bowel disease (IBD). His study reveals that individuals with Crohn's disease and ulcerative colitis have increased levels of fecal neopterin, a metabolite of cyclic guanosine monophosphate, which is released by activated T-lymphocytes and macrophages following induction by -interferon. Further, he has determined that IBD severity also significantly correlates with the level of fecal neopterin. Among Crohn's disease patients, fecal neopterin was higher in those with either clinically active or inactive disease than in healthy subjects. For ulcerative colitis patients, fecal neopterin concentration was higher in those with active disease than in those with inactive disease or healthy controls. Neither serum nor urine neopterin concentrations were increased in patients with active IBD.

Application area

  • Diagnosis of inflammatory bowel diseases
    • Crohn's disease
    • Ulcerative colitis

Advantages

  • Fecal Detection of biomarkers
  • Non-invasive

由于技术保密工作限制,技术信息无法完全展现,请通过邮箱或短信联系我们,获取更多技术资料。

More information

Categories
  • Information technology
  • Gastroenterology
Keywords:

cyclic guanosine monophosphate

inflammatory bowel disease

urine neopterin concentrations

fecal neopterin concentration

ulcerative colitis patients

下载 PDF 文档


感兴趣

Contact us

知繁业茂-yintrust logo知繁业茂-Branchly Innovation logo 知繁业茂-autmasia logo迈科技 logo